Sep 2026· Theoretical and Natural Science· 0 citations
TL;DR
The results show that the LRRK2-G2019S mutation causes excessive LRRK2 expression in brain regions that affect higher-level visual processing, while simultaneously inhibiting dopamine activity in the nucleus accumbens and viscerocortical sensory feedback, leading to impaired visual processing and impaired integration of visual information in two-dimensional space.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of dopamine-carrying neurons in the substantia nigra in the brain. Non-motor symptoms (particularly visual impairment) significantly impair patients' quality of life, but the primary pathogenesis is poorly understood. This study aims to investigate the mechanisms by which the brain uses structural changes in the enzyme leucine-rich ribonuclease 2 (LRRK2) to process visual information, with a particular focus on abnormalities in top-down brain control and bottom-up sensory pathways. The results show that the LRRK2-G2019S mutation causes excessive LRRK2 expression in brain regions that affect higher-level visual processing, such as attention and working memory, while simultaneously inhibiting dopamine activity in the nucleus accumbens and viscerocortical sensory feedback, leading to impaired visual processing and impaired integration of visual information in two-dimensional space. This results in visual problems ranging from blurred and reduced vision to unusual dreams. This ongoing study uses LRRK2-G2019S mutant fruit flies, which will allow us to identify and investigate causal relationships from LRRK2 molecular pathology to visual network abnormalities and behavioral disorders. This study provides a new rationale for screening and identifying possible early signs (e.g., vision changes, abnormal eye movement patterns, and changes in body functions), so that early intervention in PD may be possible before the disease has spread throughout the body.
The goal is to establish a comprehensive framework that positions the dorsal striatum as a shared therapeutic target for cognitive dysfunction across various diseases, thereby offering valuable insights for the development of early diagnostic biomarkers and innovative intervention strategies.
Wen Yan, Shu-Han Zhang, Wen Yan et al.· Current Neuropharmacology· 0 citations
A dual-gradient architecture is revealed that reflects the functional heterogeneity of the SN and offers new markers, grounded in behaviour and pathology, for stratifying neurodegenerative disease risk in aging, PD and AD.
D. Veréb, Blanca Zufiria-Gerbolés, M. Passaretti et al.· Molecular Psychiatry· 0 citations
Progressive, age-dependent remodeling of motor cortex somatotopic remodeling is demonstrated in 5XFAD mice, characterized by early expansion of specific simple movement cortical sites followed by deterioration of both complex and simple motor cortical maps as disease advances.
SE Moss, Cassandra C. Wolsh, Rmii Brown et al.· bioRxiv· 0 citations
An anatomically precise, effector-specific alterations suggest compensatory recruitment of cerebellar circuits in Parkinson's disease and provide a framework for targeting motor subcircuits in rehabilitation, including dance-based interventions.
C. Theofanopoulou, N. Bajaj, Alberto Muñoz Sánchez et al.· Brain Communications· 0 citations
AD should be considered a disorder of consciousness and should motivate further investigation into the dimensions of awareness affected by the disorder with implications for treatment and management of people with dementia.
J. Huntley, B. Barnett, D. Bor et al.· medRxiv· 0 citations
Improved movement initiation and increased impulsivity under stimulation of the subthalamic nucleus are linked to a shared anatomical and functional substrate, namely the subthalamic nucleus-supplementary motor cortex loop supporting automatic response inhibition.
Garance M. Meyer, Marion Albares, Guillaume Lio et al.· Brain Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.